Cornerstone Advisors (Washington)’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-1,948
| Closed | -$80K | – | 867 |
|
2019
Q2 | $80K | Buy |
1,948
+414
| +27% | +$17K | 0.01% | 291 |
|
2019
Q1 | $62K | Buy |
1,534
+583
| +61% | +$23.6K | 0.01% | 307 |
|
2018
Q4 | $36K | Buy |
951
+210
| +28% | +$7.95K | 0.01% | 368 |
|
2018
Q3 | $29K | Buy |
741
+160
| +28% | +$6.26K | 0.02% | 451 |
|
2018
Q2 | $20K | Buy |
581
+243
| +72% | +$8.37K | 0.01% | 500 |
|
2018
Q1 | $12K | Buy |
338
+160
| +90% | +$5.68K | 0.01% | 561 |
|
2017
Q4 | $6K | Hold |
178
| – | – | ﹤0.01% | 658 |
|
2017
Q3 | $6K | Sell |
178
-187
| -51% | -$6.3K | ﹤0.01% | 656 |
|
2017
Q2 | $12K | Buy |
365
+187
| +105% | +$6.15K | 0.01% | 555 |
|
2017
Q1 | $6K | Hold |
178
| – | – | ﹤0.01% | 660 |
|
2016
Q4 | $5K | Sell |
178
-840
| -83% | -$23.6K | ﹤0.01% | 697 |
|
2016
Q3 | $33K | Hold |
1,018
| – | – | 0.03% | 330 |
|
2016
Q2 | $31K | Buy |
1,018
+124
| +14% | +$3.78K | 0.03% | 211 |
|
2016
Q1 | $25K | Sell |
894
-139
| -13% | -$3.89K | 0.03% | 248 |
|
2015
Q4 | $35K | Sell |
1,033
-404
| -28% | -$13.7K | 0.04% | 230 |
|
2015
Q3 | $46K | Buy |
1,437
+91
| +7% | +$2.91K | 0.04% | 187 |
|
2015
Q2 | $43K | Buy |
1,346
+48
| +4% | +$1.53K | 0.04% | 179 |
|
2015
Q1 | $44K | Buy |
1,298
+290
| +29% | +$9.83K | 0.03% | 199 |
|
2014
Q4 | $35K | Buy |
1,008
+114
| +13% | +$3.96K | 0.03% | 214 |
|
2014
Q3 | $32K | Hold |
894
| – | – | 0.03% | 99 |
|
2014
Q2 | $33K | Sell |
894
-24
| -3% | -$886 | 0.03% | 108 |
|
2014
Q1 | $30K | Buy |
918
+36
| +4% | +$1.18K | 0.04% | 106 |
|
2013
Q4 | $26K | Hold |
882
| – | – | 0.04% | 92 |
|
2013
Q3 | $23K | Hold |
882
| – | – | 0.04% | 95 |
|
2013
Q2 | $21K | Buy |
+882
| New | +$21K | 0.05% | 52 |
|